Corcept Therapeutics Incorporated (CORT) Jumps 7.62% on January 29

Equities Staff |

Corcept Therapeutics Incorporated (CORT) was among the biggest gainers on the Russell 2000 for Friday January 29 as the stock popped 7.62% to $3.53, representing a gain of $0.25 per share. Some 389,535 shares traded hands on 2,441 trades, compared with an average daily volume of 292,297 shares out of a total float of 108.78 million. The stock opened at $3.31 and traded with an intraday range of $3.59 to $3.31.

After today's gains, Corcept Therapeutics Incorporated reached a market cap of $383.98 million. Corcept Therapeutics Incorporated has had a trading range between $7.67 and $2.76 over the last year, and it had a 50-day SMA of $4.58 and a 200-day SMA of $5.07.

Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders associated with thesteroid hormone cortisol.

Corcept Therapeutics Incorporated is based out of Menlo Park, CA and has some 57 employees. Its CEO is Joseph K. Belanoff.

For a complete fundamental analysis analysis of Corcept Therapeutics Incorporated, check out’s Stock Valuation Analysis report for CORT. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

CMX Gold & Silver Corp.

CMX Gold & Silver Corp is an exploration stage company. The Company is engaged in the acquisition, exploration and development of silver and copper/gold properties in the USA.

Private Markets


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…


Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…